BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34291393)

  • 1. Study of DYRK1B gene expression and its association with metabolic syndrome in a small cohort of Egyptians.
    Mohamed YA; Hassaneen HM; El-Dessouky MA; Safwat G; Hassan NA; Amr K
    Mol Biol Rep; 2021 Jul; 48(7):5497-5502. PubMed ID: 34291393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DYRK1B haploinsufficiency in a family with metabolic syndrome and abnormal cognition.
    Orenstein N; Gofin Y; Shomron N; Ruhrman-Shahar N; Magal N; Hagari O; Azulay N; Bazak L; Goldberg Y; Basel-Salmon L
    Clin Genet; 2022 Feb; 101(2):265-266. PubMed ID: 34786696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A form of the metabolic syndrome associated with mutations in DYRK1B.
    Keramati AR; Fathzadeh M; Go GW; Singh R; Choi M; Faramarzi S; Mane S; Kasaei M; Sarajzadeh-Fard K; Hwa J; Kidd KK; Babaee Bigi MA; Malekzadeh R; Hosseinian A; Babaei M; Lifton RP; Mani A
    N Engl J Med; 2014 May; 370(20):1909-1919. PubMed ID: 24827035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.
    Abu Jhaisha S; Widowati EW; Kii I; Sonamoto R; Knapp S; Papadopoulos C; Becker W
    Sci Rep; 2017 Jul; 7(1):6420. PubMed ID: 28743892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome and DYRK1B.
    Morita H; Komuro I
    N Engl J Med; 2014 Aug; 371(8):785. PubMed ID: 25140975
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolic syndrome and DYRK1B.
    He JL; Qiao GF; Li BY
    N Engl J Med; 2014 Aug; 371(8):785. PubMed ID: 25140974
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolic syndrome and DYRK1B.
    Mirshahi T; Murray MF; Carey DJ
    N Engl J Med; 2014 Aug; 371(8):784-5. PubMed ID: 25140973
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolic syndrome and DYRK1B.
    Keramati AR; Fathzadeh M; Mani A
    N Engl J Med; 2014 Aug; 371(8):785-6. PubMed ID: 25140972
    [No Abstract]   [Full Text] [Related]  

  • 9. DYRK1B variant linked to autosomal dominant metabolic syndrome.
    Hickmott J
    Clin Genet; 2015 Jan; 87(1):30-1. PubMed ID: 25092113
    [No Abstract]   [Full Text] [Related]  

  • 10. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.
    Chen Y; Wang S; He Z; Sun F; Huang Y; Ni Q; Wang H; Wang Y; Cheng C
    Hum Pathol; 2017 Aug; 66():48-58. PubMed ID: 28554575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of two DYRK1B variants causative of AOMS3.
    Detro-Dassen S; Sternberg A; Lehmann SM; Schwandt K; Düsterhöft S; Becker W
    Orphanet J Rare Dis; 2024 Jun; 19(1):233. PubMed ID: 38867326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties.
    Leder S; Czajkowska H; Maenz B; De Graaf K; Barthel A; Joost HG; Becker W
    Biochem J; 2003 Jun; 372(Pt 3):881-8. PubMed ID: 12633499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of irisin and oxidative stress with biochemical parameters in patients with metabolic syndrome.
    Hassan II; Hassan AB; Rajab HA; Saadi FS; Abdulah DM; Abdul Majeed AA; Khaleel BB; Taher SM; Ahmed IH
    Horm Mol Biol Clin Investig; 2019 Aug; 39(1):. PubMed ID: 31377738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the metabolic syndrome on bone mass density: a prospective case control study.
    Alhazidou E; Pergialiotis V; Panagopoulos P; Chrelias C; Hatziagelaki E; Papantoniou N; Trakakis E
    Horm Mol Biol Clin Investig; 2017 Oct; 33(3):. PubMed ID: 29087956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome.
    Doghish AS; Elsisi AM; Amin AI; Abulsoud AI
    Can J Diabetes; 2021 Oct; 45(7):614-618. PubMed ID: 33582040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome and cardiovascular risk factors among voluntary screened middle-aged and elderly Egyptians.
    Abd Elaziz KM; Gabal MS; Aldafrawy OA; Abou Seif HA; Allam MF
    J Public Health (Oxf); 2015 Dec; 37(4):612-7. PubMed ID: 25503580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP gene expressions in obesity-associated metabolic syndrome.
    Tabur S; Oztuzcu S; Oguz E; Demiryürek S; Dagli H; Alasehirli B; Ozkaya M; Demiryürek AT
    Obes Res Clin Pract; 2016; 10(6):719-723. PubMed ID: 27010496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthropometric Cutoffs for Increased Cardiometabolic Risk Among Lebanese Adults: A Cross-Sectional Study.
    Nasreddine L; Bachir N; Kharroubi S; Chamieh MC; Mehio Sibai A; Hwalla N; Naja F
    Metab Syndr Relat Disord; 2019 Dec; 17(10):486-493. PubMed ID: 31566527
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship Between Heat Shock Protein Expression and Obesity With and Without Metabolic Syndrome.
    Sabbah NA; Rezk NA; Saad MSS
    Genet Test Mol Biomarkers; 2019 Oct; 23(10):737-743. PubMed ID: 31517511
    [No Abstract]   [Full Text] [Related]  

  • 20. Inverse Association of Plasma Molybdenum with Metabolic Syndrome in a Chinese Adult Population: A Case-Control Study.
    Li B; Huang Y; Luo C; Peng X; Jiao Y; Zhou L; Yin J; Liu L
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.